173 related articles for article (PubMed ID: 37231926)
1. Therapeutic effects of mesoderm introduction of compound glycyrrhizin injection on the treatment of rosacea.
Li S; Zhao X; Chen Y; Liu J
Skin Res Technol; 2023 May; 29(5):e13328. PubMed ID: 37231926
[TBL] [Abstract][Full Text] [Related]
2. Effects of mesotherapy introduction of compound glycyrrhizin injection on the treatment of moderate to severe acne.
Chen Y; Han W; Li S; Nie Y; Chen P; Sun J; Chen Y; Li L
J Cosmet Dermatol; 2023 Jul; 22(7):1973-1979. PubMed ID: 37036158
[TBL] [Abstract][Full Text] [Related]
3. The toxic edge-A novel treatment for refractory erythema and flushing of rosacea.
Friedman O; Koren A; Niv R; Mehrabi JN; Artzi O
Lasers Surg Med; 2019 Apr; 51(4):325-331. PubMed ID: 30311683
[TBL] [Abstract][Full Text] [Related]
4. Interventions for rosacea.
van Zuuren EJ; Fedorowicz Z; Carter B; van der Linden MM; Charland L
Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD003262. PubMed ID: 25919144
[TBL] [Abstract][Full Text] [Related]
5. Beneficial use of Cetaphil moisturizing cream as part of a daily skin care regimen for individuals with rosacea.
Laquieze S; Czernielewski J; Baltas E
J Dermatolog Treat; 2007; 18(3):158-62. PubMed ID: 17538804
[TBL] [Abstract][Full Text] [Related]
6. A randomized, controlled, split-face study of botulinum toxin and broadband light for the treatment of erythematotelangiectatic rosacea.
Tong Y; Luo W; Gao Y; Liu L; Tang Q; Wa Q
Dermatol Ther; 2022 May; 35(5):e15395. PubMed ID: 35187781
[TBL] [Abstract][Full Text] [Related]
7. Botulinum Toxin A Alleviates Persistent Erythema and Flushing in Patients with Erythema Telangiectasia Rosacea.
Yang R; Liu C; Liu W; Luo J; Cheng S; Mu X
Dermatol Ther (Heidelb); 2022 Oct; 12(10):2285-2294. PubMed ID: 35925473
[TBL] [Abstract][Full Text] [Related]
8. S2k guideline: Rosacea.
Clanner-Engelshofen BM; Bernhard D; Dargatz S; Flaig MJ; Gieler U; Kinberger M; Klövekorn W; Kuna AC; Läuchli S; Lehmann P; Nast A; Pleyer U; Schaller M; Schöfer H; Steinhoff M; Schwennesen T; Werner RN; Zierhut M; Reinholz M
J Dtsch Dermatol Ges; 2022 Aug; 20(8):1147-1165. PubMed ID: 35929658
[TBL] [Abstract][Full Text] [Related]
9. Randomised, split-face study of a dermocosmetic cream containing Sphingobioma xenophaga extract and Neurosensine
Berardesca E; Cartigliani C; Nioré M; Bonfigli A; Canchy L; Kerob D; Tan J
Skin Res Technol; 2024 Jun; 30(6):e13735. PubMed ID: 38899754
[TBL] [Abstract][Full Text] [Related]
10. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial.
Elewski BE; Fleischer AB; Pariser DM
Arch Dermatol; 2003 Nov; 139(11):1444-50. PubMed ID: 14623704
[TBL] [Abstract][Full Text] [Related]
11. Concerns and Treatment Satisfaction in Patients Being Treated With Azelaic Acid Foam for Rosacea.
Williamson T; Cameron J; McLeod K; Turner B; Quillen A; LaRose A; Lott J; Gaiser A
J Drugs Dermatol; 2019 Apr; 18(4):381-386. PubMed ID: 31013011
[TBL] [Abstract][Full Text] [Related]
12. [New possibilities in the treatment of early stages of rosacea].
Tsiskarishvili NV; Katsitadze A; Tsiskarishvili Ts
Georgian Med News; 2013 Jan; (214):23-8. PubMed ID: 23388530
[TBL] [Abstract][Full Text] [Related]
13. Advances in pharmacotherapy for rosacea: what is the current state of the art?
Dall'Oglio F; Nasca MR; Gerbino C; Micali G
Expert Opin Pharmacother; 2022 Nov; 23(16):1845-1854. PubMed ID: 36330970
[TBL] [Abstract][Full Text] [Related]
14. Adapalene vs. metronidazole gel for the treatment of rosacea.
Altinyazar HC; Koca R; Tekin NS; Eştürk E
Int J Dermatol; 2005 Mar; 44(3):252-5. PubMed ID: 15807740
[TBL] [Abstract][Full Text] [Related]
15. Topical metronidazole maintains remissions of rosacea.
Dahl MV; Katz HI; Krueger GG; Millikan LE; Odom RB; Parker F; Wolf JE; Aly R; Bayles C; Reusser B; Weidner M; Coleman E; Patrignelli R; Tuley MR; Baker MO; Herndon JH; Czernielewski JM
Arch Dermatol; 1998 Jun; 134(6):679-83. PubMed ID: 9645635
[TBL] [Abstract][Full Text] [Related]
16. Brimonidine tartrate for the treatment of facial flushing and erythema in rosacea.
Tong LX; Moore AY
Expert Rev Clin Pharmacol; 2014 Sep; 7(5):567-77. PubMed ID: 25091290
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Skin Physiology Change and Safety After Intradermal Injections With Botulinum Toxin: A Randomized, Double-Blind, Placebo-Controlled, Split-Face Pilot Study in Rosacea Patients With Facial Erythema.
Kim MJ; Kim JH; Cheon HI; Hur MS; Han SH; Lee YW; Choe YB; Ahn KJ
Dermatol Surg; 2019 Sep; 45(9):1155-1162. PubMed ID: 30730346
[TBL] [Abstract][Full Text] [Related]
18. [Angioprotectors in the treatment of rosacea].
Tsiskarishvili NV; Katsitadze A; Tsiskarishvili Ts; Tchitanava L; Tsiskarishvili NI
Georgian Med News; 2014 Mar; (228):51-4. PubMed ID: 24743122
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin for the treatment of refractory erythema and flushing of rosacea.
Park KY; Hyun MY; Jeong SY; Kim BJ; Kim MN; Hong CK
Dermatology; 2015; 230(4):299-301. PubMed ID: 25765295
[TBL] [Abstract][Full Text] [Related]
20. Preparation and evaluation of topical microemulsion system containing metronidazole for remission in rosacea.
Tirnaksiz F; Kayiş A; Çelebi N; Adişen E; Erel A
Chem Pharm Bull (Tokyo); 2012; 60(5):583-92. PubMed ID: 22689395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
